Skip to main content

Table 1 Demographic and socioeconomic profile of patients by risk level

From: Healthcare resource utilization in patients on lipid-lowering therapies outside Western Europe and North America: findings of the cross-sectional observational International ChoLesterol management Practice Study (ICLPS)

 

Low Risk

(n = 70)

Moderate Risk

(n = 411)

High Risk

(n = 2621)

Very-High Risk

(n = 4842)

Risk Non-Assessable

(n = 1105)

All

(N = 9049)

Mean (SD) age, years

37.6 (5.7)

51.8 (10.3)

57.5 (11.3)

63.3 (10.7)

57.6 (12.4)

60.2 (11.7)

Male

8 (11.4)

171 (41.6)

1152 (44.0)

3136 (64.8)

508 (46.0)

4975 (55.0)

Ethnicity

n = 70

n = 411

n = 2621

n = 4842

n = 1105

n = 9049

 Asian/South Asian/Indian

34 (48.6)

163 (39.7)

1442 (55.0)

1765 (36.5)

515 (46.6)

3919 (43.3)

 Black African

1 (1.4)

2 (0.5)

52 (2.0)

47 (1.0)

20 (1.8)

122 (1.3)

 Caucasian/European

14 (20.0)

109 (26.5)

490 (18.7)

1829 (37.8)

232 (21.0)

2674 (29.6)

 Native Latin American

5 (7.1)

34 (8.3)

256 (9.8)

357 (7.4)

144 (13.0)

796 (8.8)

 Oriental/Arab/Persian

6 (8.6)

41 (10.0)

157 (6.0)

490 (10.1)

62 (5.6)

756 (8.4)

 Other

10 (14.3)

62 (15.1)

224 (8.5)

354 (7.3)

132 (11.9)

782 (8.6)

Geographical region

n = 70

n = 411

n = 2621

n = 4842

n = 1105

n = 9049

 Africa

1 (1.4)

20 (4.9)

266 (10.1)

504 (10.4)

90 (8.1)

881 (9.7)

 Asia

23 (32.9)

135 (32.8)

1335 (50.9)

1581 (32.7)

472 (42.7)

3546 (39.2)

 Eastern Europe

2 (2.9)

27 (6.6)

66 (2.5)

699 (14.4)

52 (4.7)

846 (9.3)

 Latin America

19 (27.1)

140 (34.1)

554 (21.1)

837 (17.3)

336 (30.4)

1886 (20.8)

 Middle East

25 (35.7)

89 (21.7)

400 (15.3)

1221 (25.2)

155 (14.0)

1890 (20.9)

Residence location

n = 70

n = 411

n = 2621

n = 4842

n = 1105

n = 9049

 Urban area

60 (85.7)

351 (85.4)

2126 (81.1)

3779 (78.0)

908 (82.2)

7224 (79.8)

 Rural area

3 (4.3)

32 (7.8)

252 (9.6)

515 (10.6)

99 (9.0)

901 (10.0)

 Suburban area

7 (10.0)

28 (6.8)

243 (9.3)

548 (11.3)

98 (8.9)

924 (10.2)

Educational level

n = 70

n = 411

n = 2619

n = 4833

n = 1102

n = 9035

 Illiterate

2 (2.9)

12 (2.9)

114 (4.4)

290 (6.0)

40 (3.6)

458 (5.1)

 Primary

8 (11.4)

60 (14.6)

613 (23.4)

1125 (23.3)

200 (18.1)

2006 (22.2)

 Secondary

19 (27.1)

143 (34.8)

958 (36.6)

1837 (38.0)

379 (34.4)

3336 (36.9)

 University/Higher

41 (58.6)

196 (47.7)

934 (35.7)

1581 (32.7)

483 (43.8)

3235 (35.8)

Health insurance

n = 70

n = 411

n = 2621

n = 4842

n = 1105

n = 9049

 National health service/ public health insurance

23 (32.9)

165 (40.1)

970 (37.0)

2781 (57.4)

452 (40.9)

4391 (48.5)

 Private health insurance

16 (22.9)

130 (31.6)

457 (17.4)

657 (13.6)

234 (21.2)

1494 (16.5)

 National health insurance/ public health insurance + private health insurance

2 (2.9)

12 (2.9)

95 (3.6)

240 (5.0)

24 (2.2)

373 (4.1)

 No coverage

27 (38.6)

94 (22.9)

824 (31.4)

958 (19.8)

307 (27.8)

2210 (24.4)

 Unknown

2 (2.9)

10 (2.4)

275 (10.5)

205 (4.2)

88 (8.0)

580 (6.4)

Insurance includes drug reimbursement

n = 41

29 (70.7)

n = 307

199 (64.8)

n = 1522

1005 (66.0)

n = 3674

2581 (70.3)

n = 708

426 (60.2)

n = 6252

4240 (67.8)

Employment status

n = 70

n = 410

n = 2620

n = 4842

n = 1105

n = 9047

 Full-time

42 (60.0)

230 (56.1)

978 (37.3)

1452 (30.0)

450 (40.7)

3152 (34.8)

 Part-time

10 (14.3)

25 (6.1)

131 (5.0)

230 (4.8)

52 (4.7)

448 (5.0)

 Not employed/retired

18 (25.7)

155 (37.8)

1511 (57.7)

3160 (65.3)

603 (54.6)

5447 (60.2)

  1. Data are presented as n (%) unless otherwise stated
  2. n, number of patients in the sample population; SD, standard deviation